The meta-analysis of the few available studies indicate that fiber supplements might provide benefits to NAFLD populations based on measurements of at least some of the metabolic and liver-related biomarkers (i.e., BMI, ALT, and AST outcomes). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.